Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174895 | SCV000226288 | benign | not specified | 2015-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313034 | SCV000848154 | likely benign | Inborn genetic diseases | 2016-11-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000895202 | SCV001039231 | benign | not provided | 2024-12-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000895202 | SCV005210531 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000895202 | SCV001929826 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000895202 | SCV001966771 | likely benign | not provided | no assertion criteria provided | clinical testing |